Member

AdraCard


AdraCard develops a proprietary, credit card-sized powder nasal spray platform for rescue medications used in sudden medical emergencies. Rescue medication only works if it is with the patient when the crisis occurs. By designing a device that fits seamlessly into a phone case, wallet, or pocket, AdraCard aims to solve the core problem of non-carriage and complacency, enabling constant access to life-saving medication in conditions such as anaphylaxis, seizure clusters, opioid overdose, hypoglycaemia, and migraine, beginning with adrenaline for anaphylaxis as its lead indication.

Industries

Medical Equipment Manufacturing

Nr. of Employees

small (1-50)

AdraCard is currently seeking investment

AdraCard is seeking a seed investment in the range of 5m-20m

All Investment-seeking Members

Products

Proprietary adrenaline drug delivery platform

A device-platform enabling accessible, stable, and easy administration of adrenaline for anaphylaxis in daily life settings.

Expertise Areas

  • Anaphylaxis treatment innovation
  • Drug-device development
  • Medical device usability
  • Emergency drug delivery systems

Key Technologies

  • Drug delivery systems
  • Temperature-stable medication formulations
  • Needle-free or user-friendly administration technology

Key People

Founder & CEO

Founder & CTO

Head of Quality and Reg

Head of Product Development

Advisory Board Member

Advisory Board Member

View All People

Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.